<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>38 cases of ischemic <z:e sem="disease" ids="C0038454" disease_type="Disease or Syndrome" abbrv="">apoplexy</z:e> were randomly divided into three groups </plain></SENT>
<SENT sid="1" pm="."><plain>Among them 26 cases were treated with type I and type III of Buyang Huanwu Tang Granule (BYHWTG) for 10 weeks, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>The other 12 cases served as a control group </plain></SENT>
<SENT sid="3" pm="."><plain>The results showed that clinical cure and markedly effective rate were 42.3%, the total effective rate was 88.5% in BYHWTG group </plain></SENT>
<SENT sid="4" pm="."><plain>The effective rate of BYHWTG type I for the treatment of ischemic <z:e sem="disease" ids="C0038454" disease_type="Disease or Syndrome" abbrv="">apoplexy</z:e> was 100% and it was superior to type III (84.6) </plain></SENT>
<SENT sid="5" pm="."><plain>BYHWTG could significantly improve hemorheologic indexes in the patients of ischemic <z:e sem="disease" ids="C0038454" disease_type="Disease or Syndrome" abbrv="">apoplexy</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The activity of RBC <z:chebi fb="199" ids="26708">sodium</z:chebi> pump was markedly raised from 0.210 +/- 0.003 to 0.250 +/- 0.008 1/h (P &lt; 0.001) in BYHWTG type I </plain></SENT>
<SENT sid="7" pm="."><plain>The results of this study suggested that BYHWTG had evident efficacy in the treatment of ischemic <z:e sem="disease" ids="C0038454" disease_type="Disease or Syndrome" abbrv="">apoplexy</z:e> </plain></SENT>
</text></document>